BTC $72,255.75 +12.32%
ETH $2,288.21 +19.36%
BNB $643.60 +6.89%
XRP $1.13 +15.05%
SOL $87.47 +13.30%
TRX $0.3342 +0.46%
DOGE $0.0767 +9.89%
ADA $0.1917 +10.37%
BCH $216.82 +6.62%
LINK $10.62 +9.23%
HYPE $73.48 +26.21%
AAVE $97.79 +11.32%
SUI $0.7276 +10.88%
XLM $0.1785 +14.45%
ZEC $561.28 +11.17%
BTC $72,255.75 +12.32%
ETH $2,288.21 +19.36%
BNB $643.60 +6.89%
XRP $1.13 +15.05%
SOL $87.47 +13.30%
TRX $0.3342 +0.46%
DOGE $0.0767 +9.89%
ADA $0.1917 +10.37%
BCH $216.82 +6.62%
LINK $10.62 +9.23%
HYPE $73.48 +26.21%
AAVE $97.79 +11.32%
SUI $0.7276 +10.88%
XLM $0.1785 +14.45%
ZEC $561.28 +11.17%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.